Minimally Invasive Glaucoma Surgery: A Review of the Literature
Minimally invasive glaucoma surgery (MIGS) has emerged as a novel approach in the glaucoma treatment spectrum, offering a range of diverse procedures and devices aimed at reducing intraocular pressure (IOP). MIGS can be broadly classified into several categories: those that enhance trabecular outflo...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-08-01
|
Series: | Vision |
Subjects: | |
Online Access: | https://www.mdpi.com/2411-5150/7/3/54 |
_version_ | 1797576374191390720 |
---|---|
author | Michael Balas David J. Mathew |
author_facet | Michael Balas David J. Mathew |
author_sort | Michael Balas |
collection | DOAJ |
description | Minimally invasive glaucoma surgery (MIGS) has emerged as a novel approach in the glaucoma treatment spectrum, offering a range of diverse procedures and devices aimed at reducing intraocular pressure (IOP). MIGS can be broadly classified into several categories: those that enhance trabecular outflow (Trabectome, iStent, Hydrus Microstent, Kahook Dual Blade, high frequency deep sclerotomy, and gonioscopy-assisted transluminal trabeculotomy), those that augment suprachoroidal outflow (CyPass Microstent and iStent Supra), those that target Schlemm’s canal (TRAB360 and the OMNI Surgical System, Streamline, and Ab Interno Canaloplasty), and conjunctival bleb-forming procedures (EX-PRESS Glaucoma Filtration Device, Xen Gel Stent and PreserFlo MicroShunt). MIGS is considered to have a shorter surgical time and fewer severe complications when compared to traditional glaucoma surgeries such as trabeculectomy and glaucoma drainage device implantation (Ahmed, Baerveldt, and Molteno valves). This literature review comprehensively examines the distinct MIGS devices and procedures, their underlying mechanisms, and clinical outcomes, emphasizing the importance of evaluating the efficacy and complications of each approach individually. As the field of MIGS continues to evolve, it is crucial to prioritize high-quality, long-term studies to better understand the safety and effectiveness of these innovative interventions in glaucoma management. |
first_indexed | 2024-03-10T21:51:16Z |
format | Article |
id | doaj.art-2a78e12ea2e04b98a4ae63f1fd33736e |
institution | Directory Open Access Journal |
issn | 2411-5150 |
language | English |
last_indexed | 2024-03-10T21:51:16Z |
publishDate | 2023-08-01 |
publisher | MDPI AG |
record_format | Article |
series | Vision |
spelling | doaj.art-2a78e12ea2e04b98a4ae63f1fd33736e2023-11-19T13:24:26ZengMDPI AGVision2411-51502023-08-01735410.3390/vision7030054Minimally Invasive Glaucoma Surgery: A Review of the LiteratureMichael Balas0David J. Mathew1Temerty Faculty of Medicine, University of Toronto, Toronto, ON M5S 1A8, CanadaDonald K. Johnson Eye Institute, Krembil Research Institute, University Health Network, Toronto, ON M5T 0S8, CanadaMinimally invasive glaucoma surgery (MIGS) has emerged as a novel approach in the glaucoma treatment spectrum, offering a range of diverse procedures and devices aimed at reducing intraocular pressure (IOP). MIGS can be broadly classified into several categories: those that enhance trabecular outflow (Trabectome, iStent, Hydrus Microstent, Kahook Dual Blade, high frequency deep sclerotomy, and gonioscopy-assisted transluminal trabeculotomy), those that augment suprachoroidal outflow (CyPass Microstent and iStent Supra), those that target Schlemm’s canal (TRAB360 and the OMNI Surgical System, Streamline, and Ab Interno Canaloplasty), and conjunctival bleb-forming procedures (EX-PRESS Glaucoma Filtration Device, Xen Gel Stent and PreserFlo MicroShunt). MIGS is considered to have a shorter surgical time and fewer severe complications when compared to traditional glaucoma surgeries such as trabeculectomy and glaucoma drainage device implantation (Ahmed, Baerveldt, and Molteno valves). This literature review comprehensively examines the distinct MIGS devices and procedures, their underlying mechanisms, and clinical outcomes, emphasizing the importance of evaluating the efficacy and complications of each approach individually. As the field of MIGS continues to evolve, it is crucial to prioritize high-quality, long-term studies to better understand the safety and effectiveness of these innovative interventions in glaucoma management.https://www.mdpi.com/2411-5150/7/3/54minimally invasive glaucoma surgeryMIGSglaucomaintraocular pressuretrabecular outflowsuprachoroidal outflow |
spellingShingle | Michael Balas David J. Mathew Minimally Invasive Glaucoma Surgery: A Review of the Literature Vision minimally invasive glaucoma surgery MIGS glaucoma intraocular pressure trabecular outflow suprachoroidal outflow |
title | Minimally Invasive Glaucoma Surgery: A Review of the Literature |
title_full | Minimally Invasive Glaucoma Surgery: A Review of the Literature |
title_fullStr | Minimally Invasive Glaucoma Surgery: A Review of the Literature |
title_full_unstemmed | Minimally Invasive Glaucoma Surgery: A Review of the Literature |
title_short | Minimally Invasive Glaucoma Surgery: A Review of the Literature |
title_sort | minimally invasive glaucoma surgery a review of the literature |
topic | minimally invasive glaucoma surgery MIGS glaucoma intraocular pressure trabecular outflow suprachoroidal outflow |
url | https://www.mdpi.com/2411-5150/7/3/54 |
work_keys_str_mv | AT michaelbalas minimallyinvasiveglaucomasurgeryareviewoftheliterature AT davidjmathew minimallyinvasiveglaucomasurgeryareviewoftheliterature |